Glucagon-like peptide-1 (GLP-1) is a hormone your intestines release when you eat, signaling fullness to your brain and slowing stomach emptying
As mentioned, GLP-1RAs are increasingly used in the treatment of T2MD owing to their following advantages: lowering of the levels of blood glucose, reducing body weight, improving the function of islet, and exerting potential cardiovascular benefits (206)
This comes from both increased calorie burning (higher resting metabolic rate) and enhanced fat mobilization from storage
Its filling without being heavy and is a great way to start your day with a hefty dose of protein and fiber
We also emphasize a comprehensive approach to weight management , combining medication with nutrition, exercise, and behavioral support to maximize long-term success
Can I switch providers later